Wnt-3a utilizes a novel low dose and rapid pathway that does not require casein kinase 1-mediated phosphorylation of Dvl to activate beta-catenin

BRYJA, Vítězslav, G. SCHULTE and E. ARENAS. Wnt-3a utilizes a novel low dose and rapid pathway that does not require casein kinase 1-mediated phosphorylation of Dvl to activate beta-catenin. Cellular Signalling. 2007, vol. 19, p. 610-616. ISSN 0898-6568.

Basic information

Original name

Wnt-3a utilizes a novel low dose and rapid pathway that does not require casein kinase 1-mediated phosphorylation of Dvl to activate beta-catenin

Authors

BRYJA, Vítězslav, G. SCHULTE and E. ARENAS

Edition

Cellular Signalling, 2007, 0898-6568

---

Other information

Type of outcome

Článek v odborném periodiku

Confidentiality degree

není předmětem státního či obchodního tajemství

Impact factor

Impact factor: 4.147

Organization unit

Faculty of Science

UT WoS

000244242800020